Most Popular
-
1
1 in 3 Koreans live alone, family types becoming diverse
-
2
Korea, Japan finance chiefs vow to tame rampant FX market volatility
-
3
US 'incredibly concerned' about suspected NK-Iran military ties
-
4
Sewol victims commemorated on tragedy's 10th anniversary
-
5
K-pop group's manager dismissed for setting up spycam in theater dressing room
-
6
Chanel, Louis Vuitton see muted growth in Korea
-
7
K-pop singer lost consciousness after being hit by foul ball, cancels show
-
8
Korean Muslim YouTuber's plan to build mosque in Incheon goes viral
-
9
[Kim Seong-kon] Democracy and the future of South Korea
![[Kim Seong-kon] Democracy and the future of South Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/16/20240416050802_0.jpg&u=)
-
10
Yoon's office denies considering liberal figures for key posts
![[Kim Seong-kon] Democracy and the future of South Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/16/20240416050802_0.jpg&u=)
LabGenomics to supply advanced COVID-19 test kits to India
By Lim Jeong-yeoPublished : July 30, 2020 - 14:15
South Korea’s LabGenomics, which focuses on molecular diagnostics, said Thursday it has bagged a deal to supply advanced COVID-19 test kits to Siemens Healthineers in India.
According to the company, it has signed a 5.8 billion won ($4.8 million) contract with the Indian medical technology firm to supply real-time polymerase chain reaction test kits for COVID-19 that can detect SARS CoV-2 virus infection in 35 minutes.
This deal is worth 17.5 percent of LabGenomics’ yearly revenue in 2019.
The test kit is called LabGun COVID-19 ExoFast RT-PCR Kit, and India is the first country to have access to it.
Seeing the rapid growth in India’s infection rate, LabGenomics expects additional orders.
The company said that its kits can dramatically increase efficiency in pandemic management by allowing five-fold number of examinations per diagnostics machine.
LabGenomics hopes to export its kits to some 20 countries including the US, Canada and South Africa.
By Lim Jeong-yeo (kaylalim@heraldcorp.com)
According to the company, it has signed a 5.8 billion won ($4.8 million) contract with the Indian medical technology firm to supply real-time polymerase chain reaction test kits for COVID-19 that can detect SARS CoV-2 virus infection in 35 minutes.
This deal is worth 17.5 percent of LabGenomics’ yearly revenue in 2019.
The test kit is called LabGun COVID-19 ExoFast RT-PCR Kit, and India is the first country to have access to it.
Seeing the rapid growth in India’s infection rate, LabGenomics expects additional orders.
The company said that its kits can dramatically increase efficiency in pandemic management by allowing five-fold number of examinations per diagnostics machine.
LabGenomics hopes to export its kits to some 20 countries including the US, Canada and South Africa.
By Lim Jeong-yeo (kaylalim@heraldcorp.com)
![[Today’s K-pop] Zico drops snippet of collaboration with Jennie](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/18/20240418050702_0.jpg&u=)